Testing heart-rhythm monitoring from implanted devices
Part of Heart & circulation clinical trials.
This study checks how well implanted heart rhythm devices can detect rhythm problems in everyday patients. It may help improve detection and follow-up over the next year.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have an implanted device that monitors heart rhythm (a CRT-D, or an ICD with VR/DR chambers)
- You can sign consent and allow the study team to use your health information
- You can return to the study center for all follow-up visits for at least 12 months
- You are not in another study that could affect the study results
- If you are pregnant or might become pregnant, you cannot join
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies whether implanting a defibrillator (ICD) soon after a heart attack can lower the risk of sudden cardiac death in people with weaker heart pumping and symptoms of heart failure. It compares strategies around defibrillator implantation, aiming to improve safety and outcomes.
This study is testing a new type of implantable cardioverter-defibrillator (ICD) or cardiac resynchronization therapy defibrillator (CRT-D) called the CorSky Family. The goal is to see how well it works for people who need a device to help their heart pump properly and prevent dangerous rhythms.
This study follows patients who have a heart rhythm device (pacemaker, defibrillator, or resynchronization device) and have experienced brief episodes of fast irregular heartbeats detected by the device. The study compares treatment approaches to understand which helps patients stay healthier and feel better.
This study follows people who are scheduled to get a new ICD (a device that helps protect the heart) and asks about their experiences and quality of life. It may help doctors understand what patients feel and how people do after ICD implantation.
This study tests a new alert system for people with pacemakers or defibrillators that can send information directly to your care team. The goal is to improve how quickly problems are found and treated.
This study looks at whether implantable defibrillators can reduce dangerous heart rhythms in people with non-ischemic cardiomyopathy (heart weakness not caused by blocked heart arteries), a heart scar, and very low pumping strength despite best treatment. It compares different approaches to choosing which patients should receive these devices.
Hear when a new Appropriate and Inappropriate Shock Therapy With ICD trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.